Bio Path Holdings Inc (BPTH) Return on Assets ROA from the first quarter of 2026 to first quarter of 2024 and for the year 2026, Average High and Low, Fundamental Ratios from Mar 31 2026 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bio path Holdings inc   (BPTH)


Bio Path Holdings Inc 's ROA from the first quarter of 2026 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Bio Path Holdings Inc 's ROA in the first quarter of 2026?
Bio Path Holdings Inc recorded a cumulative net loss of $-9 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -921.57%.

However, within the Healthcare sector 926 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4683.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -68.38 % -82.15 % -43.11 % -85.28 % 26.61 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -9 -11 -12 -10 -10
Return On Assets (TTM) -921.57 % -853.61 % -589.4 % -398.42 % -283.74 %
BPTH's Total Ranking # 4683 # # 4761 # 4816 # 4803
Total Assets (TTM) in million 1 1 2 1 2
Seq. Total Assets Change -0.15 % -59.47 % 124.26 % -65.16 % -43.64 %
Seq. Net Income Change - - - - -

BPTH's 5 Years Annual ROA >> Back to BPTH Management Effectiveness >> Compare BPTH ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 445
Sector # 927
Overall # 4630

Return On Assets Statistics
High Average Low
-25.9 %
-137.28 %
-1246.15 %
(Sep 30 2014)   (Mar 31 2026)



  News about Bio path Holdings inc Return on Assets ROA

Bio-Path Holdings Pioneering Solutions for Obesity in Type 2 Diabetes Through Grb2 Innovation,

Navigating New Frontiers: Bio-Path Holdings and the Quest for Innovative Obesity Treatments in Type 2 Diabetes In an era where chronic diseases such as obesity and Type 2 diabetes have reached epidemic proportions, the quest for effective treatments is more urgent than ever. Amidst this healthcare crisis, Bio-Path Holdings Inc. has emerged as a promising player with its innovative therapeutic candidate, BP1001-A. This potential treatment not only aims to address weight management in Type 2 diabetes patients but also shines a spotlight on the underlying mechanisms of insulin resistance offering a beacon of hope for millions struggling with these interlinked conditions.At the heart of Bio-Path’s development strategy lies an extensive body of scientific evidence that highlights Growth Factor Receptor Bound Protein-2 (Grb2) as a fundamental contributor to insulin resistance. Recognising Grb2 s pivotal role provides a well-supported rationale for the emphasis on BP1001-A, which is designed to target this intricate biological pathway. By intervening at the molecular level, Bio-Path Holdings seeks to tackle one of the core issues underpinning obesity in Type 2 diabetes patients.



Financial Statements
Bio Path Holdings Inc 's Assets $ 1 million BPTH's Balance sheet
Bio Path Holdings Inc 's Income $ 0 million Quarterly BPTH's Income Statement
BPTH's Income by Division See BPTH's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change 21.84 % -80.23 % -40.17 % 62.88 % -27.39 %
Total Assets in million 4 3 16 26 16
Y / Y Net Income Change - - - - -
Net Income in million -10 -16 -14 -10 -11
Annual Return On Assets -260.44 % -515.65 % -87.92 % -39.6 % -67.23 %

BPTH's 5 Years Annual ROA >> Back to BPTH Management Effectiveness >> Compare BPTH ROA to its Competitors



More Return On Assets Ratios
BPTH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BPTH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BPTH's Competitors
Subscribers only: Roa for Bio Path Holdings Inc 's Suppliers
Subscribers only: Return On Assets for BPTH's Customers

You may also want to know
BPTH's Roi BPTH's Inventory Turnover Ratio BPTH's Growth Rates BPTH's Dividend Comparisons
BPTH's Profitability Ratios BPTH's Asset Turnover Ratio BPTH's Dividend Growth
BPTH's Roe BPTH's Valuation Ratios BPTH's Financial Strength Ratios BPTH's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector ROA

Date modified: 2026-08-30T14:47:28+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.